Insider Transactions in Q4 2020 at Atreca, Inc. (BCEL)
Insider Transaction List (Q4 2020)
| Date | Insider | Transaction | Ownership Type | Shares Traded | Value / Price |
|---|---|---|---|---|---|
|
Dec 17
2020
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
5,000
-100.0%
|
$80,000
$16.61 P/Share
|
|
Dec 17
2020
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
5,000
+50.0%
|
$20,000
$4.56 P/Share
|
|
Dec 14
2020
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.29%
|
$80,000
$16.67 P/Share
|
|
Dec 11
2020
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
10,000
-2.54%
|
$150,000
$15.87 P/Share
|
|
Nov 27
2020
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
3,175
-100.0%
|
$47,625
$15.34 P/Share
|
|
Nov 27
2020
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
3,175
+50.0%
|
$12,700
$4.56 P/Share
|
|
Nov 17
2020
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
1,825
-100.0%
|
$27,375
$15.04 P/Share
|
|
Nov 17
2020
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
1,825
+50.0%
|
$7,300
$4.56 P/Share
|
|
Nov 16
2020
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
8,847
-2.2%
|
$132,705
$15.12 P/Share
|
|
Nov 16
2020
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.27%
|
$75,000
$15.0 P/Share
|
|
Nov 12
2020
|
Tito Serafini |
BUY
Bona fide gift
|
Indirect |
3,655
+50.0%
|
-
|
|
Nov 12
2020
|
Tito Serafini |
SELL
Bona fide gift
|
Direct |
3,655
-100.0%
|
-
|
|
Nov 11
2020
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
1,153
-0.29%
|
$17,295
$15.1 P/Share
|
|
Nov 10
2020
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
4,500
-100.0%
|
$67,500
$15.1 P/Share
|
|
Nov 10
2020
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
4,500
+50.0%
|
$18,000
$4.56 P/Share
|
|
Oct 19
2020
|
Norman Michael Greenberg Chief Scientific Officer |
SELL
Open market or private sale
|
Direct |
500
-100.0%
|
$7,500
$15.12 P/Share
|
|
Oct 19
2020
|
Norman Michael Greenberg Chief Scientific Officer |
BUY
Exercise of conversion of derivative security
|
Direct |
500
+50.0%
|
$2,000
$4.56 P/Share
|
|
Oct 13
2020
|
William Hewitt Robinson Director |
SELL
Open market or private sale
|
Direct |
5,000
-1.25%
|
$75,000
$15.71 P/Share
|
|
Oct 12
2020
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
10,000
-2.44%
|
$150,000
$15.0 P/Share
|
|
Oct 06
2020
|
Tito Serafini |
SELL
Open market or private sale
|
Indirect |
1,218
-0.3%
|
$18,270
$15.05 P/Share
|